The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 21, 2019
Filed:
May. 24, 2016
Applicant:
Sun Pharmaceutical Industries Limited, Mumbai, Maharashtra, IN;
Inventors:
Ramkinkar Santra, Paschim Medinipur, IN;
Bala Krishna Reddy Bhogala, Kadapa, IN;
Chandra Has Khanduri, Gurgaon, IN;
Assignee:
Sun Pharmaceutical Industries Limited, Mumbai, IN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 493/08 (2006.01); A61P 3/10 (2006.01); C07D 207/28 (2006.01); C07D 207/22 (2006.01); A61K 31/357 (2006.01); A61K 31/401 (2006.01); C07H 1/00 (2006.01); C07H 9/04 (2006.01);
U.S. Cl.
CPC ...
C07D 493/08 (2013.01); A61K 31/357 (2013.01); A61K 31/401 (2013.01); A61P 3/10 (2018.01); C07D 207/22 (2013.01); C07D 207/28 (2013.01); C07H 1/00 (2013.01); C07H 9/04 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present invention relates to processes for the preparation of an ertugliflozin-L-pyroglutamic acid (1:1) and co-crystal ertugliflozin-L-proline (1:1) co-crystal. The present invention further relates to an ertugliflozin-L-proline (1:2) co-crystal, processes for its preparation, and its use for the treatment of type 2 diabetes mellitus.